Long-Term Outcome in Guillain-Barre Syndrome

Abstract

The long-term sequelae and early predictors of sequelae were determined in a chart review of 47 children with Guillain-Barre syndrome (GBS) of whom 30 had been treated with intravenous gammaglobulin (IVIG) at The Hospital for Sick Children, Toronto, Canada.

Keywords

• guillain-barre syndrome
• intravenous gammaglobulin
• long-term muscle